Refractory Partial Onset Epilepsy clinical trials

Explore recruiting refractory partial onset epilepsy clinical trials.

Recruiting refractory partial onset epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Partial Onset Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.

Poland, Romania, Germany, Czechia, Bulgaria, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Partial Onset Epilepsy trials by city

Refractory Partial Onset Epilepsy in Toronto Refractory Partial Onset Epilepsy in Vancouver Refractory Partial Onset Epilepsy in Montreal Refractory Partial Onset Epilepsy in Calgary Refractory Partial Onset Epilepsy in Edmonton Refractory Partial Onset Epilepsy in Ottawa Refractory Partial Onset Epilepsy in Winnipeg Refractory Partial Onset Epilepsy in Quebec City Refractory Partial Onset Epilepsy in Hamilton Refractory Partial Onset Epilepsy in Kitchener Refractory Partial Onset Epilepsy in London Refractory Partial Onset Epilepsy in Halifax Refractory Partial Onset Epilepsy in New York Refractory Partial Onset Epilepsy in Los Angeles Refractory Partial Onset Epilepsy in Chicago Refractory Partial Onset Epilepsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease